Study progress in nitrogenous heterocyclic compounds

Shiyou Huagong/Petrochemical Technology

Volumn 40, Issue 6, 2011, Pages 579-584

  Zhang, Jin ^a   Xiao, Guomin ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Dye sensitized solar cell; Nitrogenous heterocyclic compound; Organometallic catalyst

Indexed keywords

EID: 79960130089     PISSN: 10008144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Xu Yang, Xue Sijia. Synthesis and Biological Activities of Alpha-Amino Acylamines Derivatives Containing Furan and Pyridine Ring[J]. Chem Res Chin Univ, 2009, 25(6): 846-850.
2. 2007, 46(1): 1-10.
3. George P, Lahm T P, Selby J H, et al. Insecticidal Anthranilic Diamides: A New Class of Potent Ryanodine Receptor Activators[J]. Bioorg Med Chem Lett, 2005, 15(22): 4898-4906.
4. Glenmark Generics Limited. Preparation of Prasugrel and Its Hydrochloride Salt and Crystal Forms: WO, 2010070677[P]. 2010-06-24.
5. Sumitomo Chemical Company, Limited. Process for Producing Low-Melting Crystals of Disopyramide Free Base: WO, 2005014548[P]. 2005-02-17.
6. Dipharma Francis S. r. l. Preparation Method of Azelnidipine Crystal: JP, 2010083888[P]. 2010-04-15.
7. Societa'Italiana Medicinali Scandicci S.I.M.S. S.r.l. Process for the Preparation of Torsemide by Addition of 4-[(3-Methylphenyl)Amino]-3-Pyridinesulfonamide to Isopropyl Isocyanate: IT, 1343259[P]. 2007-12-19.
8. Boehringer Ingelheim International G.m.b.H., Boehringer Ingelheim Pharma G.m.b.H. & Co. K.-G. Improved Process for the Preparation of the Salts of 4-(Benzimidazolylmethylamino)Benzamides: WO, 2007071743[P]. 2007-06-28.
9. 2009, 19(4): 261-262.
10. 2010.
11. SRI International. Methods of Treating Conditions Associated with an Edg-7 Receptor: US, 2005261298[P]. 2005-11-24.
12. Hamid M, Haniti S A, Allen C, et al. Ruthenium-Catalyzed N-Alkylation of Amines and Sulfonamides Using Borrowing Hydrogen Methodology[J]. J Am Chem Soc, 2009, 131(5): 1766-1774.
13. Cadila Healthcare Limited. Process for Preparation of Highly Pure Rupatadine and Intermediates: IN, 2006MU00864[P]. 2008-07-04.
14. Ware E C, Kiel J S, Thomas H, et al. In Process Conversion Method for Preparing Tannate Tablet, Capsule or Other Solid Dosage Forms: US, 2005202080[P]. 2005-09-15.
15. 2006, 37(11): 726-727.
16. Hanmi Pharm. Co., Ltd., S. Process for Preparing Bepotastine and Intermediates Used Therein: WO, 2008153289[P]. 2008-12-18.
17. Ochi T, Sakamoto M, Minamida A, et al. Syntheses and Properties of the Major Hydroxy Metabolites in Humans of Blonanserin AD-5423, a Novel Antipsychotic Agent[J]. Bioorg Med Chem Lett, 2005, 15(4): 1055-1059.
18. 2009, 25(5): 493-495.
19. Sripathi S, Bojja R R, Karnati V R. An Improved Synthesis of Antiulcerative Drug: Tenatoprazole[J]. Org Process Res Dev, 2009, 13(4): 804-806.
20. Honeywell International, Inc. Process for the Synthesis of 3-Hydroxy-3-(2-Phenylethyl)Hexanoic Acid, Useful as an Intermediate for Antiviral Drugs: US, 2004110957[P]. 2004-06-10.
21. Tosoh Corp. O-(5, 6, 7, 8-Tetrahydro-2-Naphthyl) N-(6-Methoxy-2-Pyridyl)-N-Methylthiocarbamate of Minimum Inorganic Salt Content and Their Preparation: JP, 2006298832[P]. 2006-11-02.
22. Sandoz A G; Wolf, Siegfried. Process for the Production of Telithromycin: WO, 2009053259[P]. 2009-04-30.
23. Wyeth L L C. Improved Process for Preparation of Coupled Products from 4-Amino-3-Cyanoquinolines Using Stabilized Intermediates: WO, 2010048477[P]. 2010-04-29.
24. Sicor Inc. Process for Preparation of Sorafenib and Intermediates Thereof: WO, 2009111061[P]. 2009-09-11.
25. Li Qingyong, Deng Xiaoqiu, Zu Yuangang, et al. Cytotoxicity and Topo: I. Targeting Activity of Substituted 10-Nitrogenous Heterocyclic Aromatic Group Derivatives of SN-38[J]. Eur J Med Chem, 2010, 45(7): 3200-3206.
26. Thapa Pritam, Karki Radha, Choi Hoyoung, et al. Synthesis of 2-(Thienyl-2-yl or-3-yl)-4-Furyl-6-Aryl Pyridine Derivatives and Evaluation of Their Topoisomerase I and II Inhibitory Activity, Cytotoxicity, and Structure-Activity Relationship[J]. Bioorg Med Chem, 2010, 18(6): 2245-2254.
27. Rook Yvonne, Schmidtke Kai-Uwe, Gaube Friedemann, et al. Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents[J]. J Med Chem, 2010, 53(9): 3611-3617.
28. Roy Sovan, Saha Sounik, Majumdar Ritankar, et al. DNA Photocleavage and Anticancer Activity of Terpyridine Copper(II) Complexes Having Phenanthroline Bases[J]. Polyhedron, 2010, 29(14): 2787-2794.
29. Bianchini C, Mantovani G, Meli A, et al. Oligomerisation of Ethylene to Linear α-Olefins by New C5-and C1-Symmetric [2, 6-Bis(Imino)Pyridyl] Iron and Cobalt Dichloride Complexes[J]. Eur J Inorg Chem, 2003, (8): 1620-1631.
30. Exxonmobil Chemical Patents Inc. Polymerization Process: WO, 2006009980 A2[P]. 2006-01-26.
31. 2007, 29(4): 7-10.
32. 2009.
33. Enders D, Kallfass U. An Efficient Nucleophilic Carbene Catalyst for the Asymmetric Benzoin Condensation[J]. Angew Chem, Int Ed, 2002, 41(10): 1743-1745.
34. Toyota Motor Corp., Tokyo University. Preparation of 2, 6-Bis[(Dialkylphosphino)Methyl]Pyridine-Molybdenum Complexes as Catalysts for Nitrogen Fixation: JP, 2010195703[P]. 2010-09-09.
35. 2010, 40(4): 366-370.
36. 2010, 31(1): 37-43.
37. 2007, 23(10): 1771-1776.
38. Wu Kuan-Lin, Hsu Hui-Chu, Chen Kellen, et al. Development of Thiocyanate-Free, Charge-Neutral Ru(II) Sensitizers for Dye-Sensitized Solar Cells[J]. Chem Commun, 2010, 46(28): 5124-5126.
39. 2(mnt)]: Comparison of Pyridyl and Bipyridyl-Based Dyes for Solar Cells[J]. Dalton Trans, 2008, (48): 6940-6947.
40. Ning Zhijun, Zhang Qiong, Wu Wenjun, et al. Novel Iridium Complex with Carboxyl Pyridyl Ligand for Dye-Sensitized Solar Cells: High Fluorescence Intensity, High Electron Injection Efficiency?[J]. J Organomet Chem, 2009, 694(17): 2705-2711.